NEUROLIXIS
Neurolixis is a clinical-stage specialty pharmaceutical company focused on developing medicines targeting unmet disorders of the nervous system. The Company has two therapeutic candidates in clinical development: NLX-112, a potential symptomatic treatment for Parkinson's disease (PD) dyskinesia, is ready for Phase 2 clinical trials.
NEUROLIXIS
Industry:
Biopharma Biotechnology Health Care
Founded:
2011-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.neurolixis.com
Total Employee:
1+
Status:
Active
Contact:
9492144017
Total Funding:
15 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Font Awesome Domain Not Resolving Apache Google Apps For Business
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.neurolixis.com Semrush global rank: 4.73 M Semrush visits lastest month: 2 K
- Host name: node52-eu.n0c.com
- IP address: 185.221.182.142
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
